laitimes

Deputy Director Jiang Wei led the team to supervise the drug safety work in Wuxi before the National Day

author:Nine factions view the world

In order to implement the normalization of epidemic prevention and control work deployment of the provincial party committee and the provincial government, as well as the relevant work requirements of the Provincial Market Supervision and Administration Bureau and the Provincial Drug Administration on doing a good job during the National Day period to ensure the quality and safety of pharmaceutical equipment, from September 23 to 24, Jiang Wei, deputy director of the Provincial Bureau, led the inspection team to conduct pre-holiday supervision and inspection of some pharmaceutical and medical device business and use units in Wuxi. The main responsible comrades of the Wuxi Municipal Market Supervision Bureau and the Wuxi Inspection Branch of the Provincial Bureau participated in the relevant activities.

Deputy Director Jiang Wei led the team to supervise the drug safety work in Wuxi before the National Day

The inspection team inspected the business premises and drug warehouses of the enterprises at Shanghai Pharmaceutical Holdings Jiangsu Co., Ltd., and inspected the management of key drugs such as drug purchase and sales channels, storage and transportation management, cold chain and temperature and humidity monitoring, information traceability system construction, special drugs, selected drugs selected by the state, and stimulants; at the Wuxi Wuai store of Jiangsu Citizen Da Pharmacy Chain Co., Ltd., they inspected the implementation of epidemic prevention and control measures, the on-the-job employment of practicing pharmacists, the purchase and sale of drugs, and the classification management In the community health service center of Dongting Street, Xishan District, Wuxi City, the vaccine cold chain room and vaccination site were inspected on the spot, and some varieties were selected to inspect the vaccine purchase channels, reception records, temperature monitoring, etc. Judging from the inspection situation, the overall situation of drug quality and safety management of the inspected enterprises (units) is good. For the general defects found in the inspection, if they can be rectified on the spot, they shall guide the enterprise (unit) to rectify immediately; if they cannot rectify immediately on the spot, the enterprise (unit) is required to formulate a rectification plan, and the territorial supervision department supervises the enterprise (unit) to implement rectification and reform, forming a closed-loop management.

The inspection team visited the Wuxi Xishan District Market Supervision Bureau and held a symposium on drug supervision, and listened to the work reports of the Wuxi Municipal Market Supervision Bureau, the Xishan District Market Supervision Bureau, the Goose Lake Branch, the Business District Bureau, the Xibei Branch and other grass-roots regulatory departments and the opinions and suggestions on strengthening the supervision work. Jiang Wei fully affirmed the achievements made by the Wuxi Market Supervision Department and the Wuxi Inspection Branch of the Provincial Bureau in the supervision of drugs and medical devices, and put forward three requirements around "keeping the bottom line, ensuring safety and promoting development". The first is to improve the political position and attach great importance to drug supervision. It is necessary to establish a bottom-line thinking and think of danger in times of peace, not only to grasp the deployment of epidemic prevention and control and the quality supervision of pharmaceutical equipment, but also to grasp the implementation, and to tilt toward safety in the allocation of regulatory resources. The second is to optimize inspection resources and form a joint inspection force. Provinces, cities and counties are a game of chess, we must do a good job in the coordination of regulatory responsibilities, integrate and optimize resources, promote benign operation, create a good environment, and promote the healthy development of the biomedical industry. The third is to innovate regulatory means and improve regulatory efficiency. It is necessary to take the initiative to plan and promote innovation, and to make full use of new technologies such as big data, blockchain, and the Internet of Things to carry out smart supervision and online supervision, and continuously improve the level of supervision capabilities.

(Provincial Bureau Pharmaceutical and Equipment Business Supervision Division, Provincial Bureau Wuxi Inspection Branch, Wuxi Municipal Market Supervision Bureau)

【Source: Jiangsu Provincial Drug Administration_Provincial Bureau Information】

Disclaimer: The copyright of this article belongs to the original author, if there is an error in the source or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will deal with it in a timely manner. Email address: [email protected]

Read on